NIH-funded research R21 grant

A new device to measure exposure to airborne biological agents

Official title: A novel passive sampler to assess personal exposures to airborne biological agents

Funded at Rutgers, the State Univ of N.j. · NIH-10914631 · Data updated 2026-11-12

This study is testing a new, easy-to-wear device that can track your exposure to airborne germs without needing batteries, helping us learn more about how these germs spread, especially in workplaces.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers, the State Univ of N.j.
NIH-funded
Lab location1 site (Piscataway, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$192,145
NIH project number5R21OH012568-02
Project IDNIH-10914631 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals working in environments where exposure to airborne biological agents is a concern.

Less likely to help

Patients who do not work in such environments or have no risk of exposure to airborne biological agents may not benefit from this research.

What this research studies

This research focuses on developing a lightweight and unobtrusive personal sampler that can monitor exposure to airborne biological agents without the need for a power source. The device, known as the Personal Rutgers Electrostatic Passive Sampler (P-REPS), utilizes innovative materials and design to capture bioaerosol particles effectively. By creating an electrostatic field, the sampler can operate for extended periods, providing valuable data on personal exposure levels in various environments. This could lead to a better understanding of how these agents are transmitted, particularly in occupational settings.

Why it matters

Potential benefit: If successful, this research could provide individuals with a reliable way to monitor their exposure to harmful airborne biological agents, potentially improving health outcomes.

How similar studies have gone: While the approach of using passive sampling devices is established, the specific design and methodology of the P-REPS device represent a novel advancement in this field.

Where this research is happening

  • Rutgers, the State Univ of N.j.
    Piscataway, United States
    Active

Researchers

  • Principal investigator: Mainelis, Gediminas — Rutgers, the State Univ of N.j.
  • Study coordinator: Mainelis, Gediminas

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.